IQ DruSafe ICH M7 Implementation Focus Group Call for (Q)SAR Vendor Participation
Recently a focus group was formed within DruSafe to consider ICH M7 implementation issues and challenges. One topic that the focus group is interested to consider is whether differences in the results of predictions (compared to previous ones) occur as new versions of (Q)SAR software become available. In order to address this topic, the focus group is seeking collaboration with (Q)SAR vendors. The aim of the collaboration is to assess a set of compounds (provided by pharmaceutical companies) which are relevant to pharmaceutical synthesis using the most contemporary software available as well as its recent historical versions to identify the frequency and significance of changes to the (Q)SAR output. The results of these analyses will support the focus group discussions and potentially best practice recommendations regarding repeating (Q)SAR analyses. If you would like to participate, please contact, Krista Dobo and Susanne Glowienke, by clicking here by 23 February.